Morgan Stanley’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-416,826
| Closed | -$4.13M | – | 7832 |
|
|
2023
Q1 | $4.13M | Buy |
416,826
+74,179
| +22% | +$735K | ﹤0.01% | 3933 |
|
|
2022
Q4 | $3.42M | Buy |
342,647
+340,695
| +17,454% | +$2.54M | ﹤0.01% | 4068 |
|
|
2022
Q3 | $11K | Hold |
1,952
| – | – | ﹤0.01% | 7054 |
|
|
2022
Q2 | $7K | Sell |
1,952
-19,085
| -91% | -$90.2K | ﹤0.01% | 7341 |
|
|
2022
Q1 | $128K | Buy |
21,037
+14,959
| +246% | +$91.2K | ﹤0.01% | 6169 |
|
|
2021
Q4 | $51K | Buy |
6,078
+2,783
| +84% | +$24.3K | ﹤0.01% | 6804 |
|
|
2021
Q3 | $30K | Buy |
3,295
+486
| +17% | +$4.18K | ﹤0.01% | 6932 |
|
|
2021
Q2 | $23K | Buy |
2,809
+283
| +11% | +$1.94K | ﹤0.01% | 6961 |
|
|
2021
Q1 | $14K | Buy |
2,526
+2,357
| +1,395% | +$11.7K | ﹤0.01% | 6851 |
|
|
2020
Q4 | $0 | Buy |
169
+134
| +383% | +$353 | ﹤0.01% | 7168 |
|
|
2020
Q3 | $0 | Hold |
35
| – | – | ﹤0.01% | 6882 |
|
|
2020
Q2 | $0 | Sell |
35
-3
| -8% | -$6 | ﹤0.01% | 6788 |
|
|
2020
Q1 | $0 | Hold |
38
| – | – | ﹤0.01% | 6786 |
|
|
2019
Q4 | $0 | Sell |
38
-3
| -7% | -$9 | ﹤0.01% | 6836 |
|
|
2019
Q3 | $0 | Buy |
41
+6
| +17% | +$19 | ﹤0.01% | 6830 |
|
|
2019
Q2 | $0 | Buy |
35
+30
| +600% | +$107 | ﹤0.01% | 6813 |
|
|
2019
Q1 | $0 | Buy |
+5
| New | +$17 | ﹤0.01% | 6771 |
|
|
2017
Q1 | – | Sell |
-5
| Closed | – | – | 6640 |
|
|
2016
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 6591 |
|
|
2016
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 6587 |
|
|
2016
Q2 | $0 | Sell |
5
-1
| -17% | -$15 | ﹤0.01% | 6710 |
|
|
2016
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 6779 |
|
|
2015
Q4 | $0 | Buy |
6
+1
| +20% | +$17 | ﹤0.01% | 6849 |
|
|
2015
Q3 | $0 | Sell |
5
-1
| -17% | -$19 | ﹤0.01% | 6767 |
|
|
2015
Q2 | $0 | Buy |
6
+1
| +20% | +$99 | ﹤0.01% | 6793 |
|
|
2015
Q1 | $1K | Sell |
5
-1
| -17% | -$230 | ﹤0.01% | 6501 |
|
|
2014
Q4 | $1K | Sell |
6
-19
| -76% | -$4.24K | ﹤0.01% | 6508 |
|
|
2014
Q3 | $6K | Sell |
25
-17
| -40% | -$4.62K | ﹤0.01% | 6306 |
|
|
2014
Q2 | $13K | Buy |
42
+37
| +740% | +$11.7K | ﹤0.01% | 6134 |
|
|
2014
Q1 | $2K | Sell |
5
-4
| -44% | -$1.45K | ﹤0.01% | 6357 |
|
|
2013
Q4 | $3K | Buy |
+9
| New | +$3.31K | ﹤0.01% | 6225 |
|
Morgan Stanley's APEN Position: Q2 2023 in Review
Morgan Stanley sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 416,826 shares — an estimated $4.13M sold.
Morgan Stanley first reported a position in APEN in Q4 2013 and held it in 30 quarters. The position peaked at $4.13M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Morgan Stanley reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Morgan Stanley sold 416,826 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $4.13M.
- Morgan Stanley first reported a position in Apollo Endosurgery, Inc. in Q4 2013 and held it in 30 quarters.
- Morgan Stanley's Apollo Endosurgery, Inc. position peaked at $4.13M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.